You are here



  • Investigate all reports of active or suspected cases of Tuberculosis
  • Ensure required follow-up has been done on all reported positive TB skin tests
  • Provide TB skin testing at our clinics
  • Provide free TB medication for prophylaxis and treatment
  • Provide information, advice on the management of LTBI and Active TB cases to healthcare providers
  • Provide multilingual resources on TB
  • Follow-up of persons under medical surveillance for Tuberculosis

Public Health TB clinics

  • Offered one Monday per month at our Guelph 160 Chancellors Way location
  • Staffed by a respirologist and public health nurses
  • We welcome written referrals from physicians and nurse practitioners. Please fax referrals to the Reportable Disease secure fax line at 1-855-WDG-LINE (1-855-934-5463)

Reporting Requirements

Tuberculosis is a reportable disease under the Health Protection and Promotion Act - R.S.O. 1990, Chapter H.7.

All physicians, laboratories, institutions, hospital administrators, and schools must report all persons with any of the following to Public Health:

  • Latent TB infection
  • Suspected active TB
  • Confirmed active TB

To report a positive Mantoux TB skin test result, use this form: Reporting Mantoux TB Skin Test (PDF).

Practice Guidelines and Resources

For detailed information on current and past BCG policies and practices for over 180 countries.

Forms and fact sheets

Reporting and Screening:

TB Testing and Medication:

TB Fact Sheets:

Interferon Gamma Release Assays (IGRA Testing)

Two Interferon Gamma Release Assays (IGRAs) are licensed for use in Canada:

  • Quantiferon TB Gold (available through Gamma-Dynacare commercial laboratories)
  •  T-SPOT TB

These tests are not covered under the Ontario Health Insurance Plan (OHIP) and cost approximately $90 each.

For more information:

Additional Resources

No additional resources found